对于莱伯遗传性视神经病变的RAAV2-ND1基因疗法
1Department of Ophthalmology, Taihe Hospital, Hubei University of Medicine, No. 32 Renmin South Road, Shiyan City, Hubei Province, China.
概括
这项研究表明,rAAV2-ND1眼内注射是一种安全有效的治疗由ND1突变引起的勒伯遗传性视神经病变 (LHON),改善患者的视力.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 神经学 神经学
背景情况:
- 勒伯遗传性视神经病变 (LHON) 是一种遗传性疾病,目前没有有效的治疗方法.
- ND1突变是LHON的常见原因之一.
- 基因疗法为LHON提供了一个潜在的治疗途径.
研究的目的:
- 评估RAAV2-ND1对LHON的静脉内注射的安全性和有效性.
- 在LHON患者中评估rAAV2-ND1的不同剂量水平.
- 为了确定rAAV2-ND1对视敏度和其他视觉功能的影响.
主要方法:
- 一项临床试验涉及12名LHON患有ND1突变的患者,分为低剂量和高剂量组.
- 在每眼1.5×10^8vg和每眼1.5×10^9vg的剂量下,对rAAV2-ND1进行单次单边静脉内注射.
- 通过不良事件监测安全性,通过最佳校正视敏度 (BCVA),视野 (VF),视野指数 (VFI),平均偏差 (MD) 和视网膜神经纤维层 (RNFL) 厚度来监测疗效.
主要成果:
- 观察到轻度,短期的与眼睛相关的不良事件并得到解决.
- 在12个月后,在低剂量组的注射眼睛中,BCVA的统计学上显著改善.
- 在高剂量组的未注射眼睛中,在治疗后3个月和6个月观察到BCVA的显著差异.
结论:
- 初步证据表明,RAAV2-ND1眼科注射对LHON.是安全有效的.
- 这种基因治疗方法对治疗由ND1突变引起的LHON具有前景.
- 进一步的研究是有必要的,以优化剂量和长期结果.
相关概念视频
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
00:59Gene Therapy
25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K